Post-approval studies (Phase 4)Looking for participantsNCT07663526
What this trial is testing
Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellvi®
Who this might be right for
Crohn's Disease
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 50